Prenatal Aneuploidy/NTD Screening |
Performed in: |
Screens for: |
First trimester Second trimester |
Trisomy 21 Trisomy 18 Other chromosome Open neural Abnormalities tube defect |
|
Non-Invasive Prenatal Testing for Fetal Aneuploidy (Panorama) |
* * |
**Trisomy 13, triploidy, sex chromosome abnormalites |
Non-Invasive Prenatal Testing for Fetal Aneuploidy (Panorama) with Microdeletions |
** |
**Trisomy 13, triploidy, sex chromosome abnormalities, 5 microdeletion syndromes |
Maternal Serum Screen, First Trimester |
* |
** |
Maternal Screening, Sequential,Specimen #1* |
** |
|
Maternal Screening,* Sequential,Specimen #2 Result based on first and second trimester samples |
*** |
|
Maternal Serum Screening, Integrated, Specimen #1 |
* |
** |
Maternal Serum Screening, Integrated, Specimen #2 |
* |
*** |
Maternal Serum Screen, Alpha Fetoprotein, hCG, Estriol, and Inhibin A |
* |
*** |
Maternal Serum Screen, Alpha Fetoprotein (Only) |
* |
* |
Products of Conception Testing
|
Chromosome Analysis, Products of Conception · Order for standard chromosome analysis performed on fetal tissue or villi |
Chromosome Analysis, Products of Conception, with Reflex to Genomic Microarray · Useful to ensure the highest chance of obtaining meaningful results from POC specimens · When tissue culture is unsuccessful or if the results of the chromosome analysis are normal, then testing reflexes to genomic microarray |
Genomic SNP Microarray, Products of Conception (2005633) · For the detection of copy number alterations and loss of heterozygosity in unfixed fetal tissue or villi |